Collectively, the above-mentioned observations suggested that, indeed, G9a has oncogenic features in HCC cells, and also highlighted that the tumor-promoting effects of G9a may be irrelevant to the HBV status of HCC cells. This evidence concerns the gene EHMT2 and hepatocellular carcinoma.